INmune Bio Inc
Biotechnology
Healthcare
INMB
22.50 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.98
52 week high
10.48
high
2.08
52 week low
0.00
low
1.98
growth
-61.88 %
previous Close
1.98
P/E ratio
market cap
69.73 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
20.70 %
eps surprise
20.08 %
net profit margin
0.00 %
194.78 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top